Autres langues Novo Nordisk A/S Nyse

Actions

Marché Fermé - Nyse Autres places de cotation 22:00:01 29/04/2024			Varia. 5j.	Varia. 1 janv.
126,9 ^USD	+0,02%		+1,29%	+22,65%

29/04	Une dose de Wegovy de Novo Nordisk à nouveau disponible, selon le site web de la FDA	RE
29/04	NOVO NORDISK : UBS maintient sa recommandation neutre	ZD

One dose of Novo Nordisk's Wegovy back in supply, FDA website shows	29/04
Big tech saves the day, again	29/04
Nanexa invites to Capital Markets Day on May 7	29/04
Borsa di Italia: Tecnologia 1 - Fed 0	29/04
WOCHENVORSCHAU: Termine bis 10. Mai 2024	26/04
WOCHENVORSCHAU/29. April bis 5. Mai (18. KW)	26/04
Nonalcoholic Steatohepatitis Market to Observe Impressive Growth During the Forecast Period \| Inventiva Pharma, Zydus Therapeutics, Novo Nordisk A/S, Eli Lilly and Company, Madrigal Pharmaceuticals	26/04
Scholz verspricht Pharma-Branche bei Merck weitere Unterstützung	25/04
Scholz promises support for pharma sector in Germany as Merck invests	25/04
Sector Update: Health Care Stocks Slipping Late Afternoon	24/04
Sector Update: Health Care	24/04
Comisión del Senado de EEUU investiga precios de medicamentos para adelgazar Ozempic y Wegovy	24/04
Novo Nordisk's Wegovy FDA Approval for Heart Health Opens Door to Medicare Access, KKF Says	24/04
US Senate committee investigates pricing of Novo's Ozempic and Wegovy	24/04
Novo Nordisk Probed by Senate Committee on Weight-Loss Drug Prices	24/04
Novo Nordisk A/S : Reduction of the share capital	24/04
Novo Nordisk A/S - Articles of Association, April 2024	24/04
Novo Nordisk A/S – Reduction of the share capital	24/04
Germany's Evotec appoints Christian Wojczewski as CEO	23/04
UK stocks may finally be back in fashion	23/04